Local recurrence of prostate cancer after radical prostatectomy


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article presents an analysis of domestic and international literature on local recurrence of prostate cancer after radical prostatectomy. The authors describe the most advanced methods of diagnosis and treatment of local recurrence commonly used in clinical practice.

Full Text

Restricted Access

About the authors

N. V Petrovskii

I.M. Sechenov First MSMU of Minzdrav of Russia (Sechenov University)

Email: n_petrovskiy@hotmail.com
Ph.D., Associate Professor at the Department of Urology

P. V Glybochko

I.M. Sechenov First MSMU of Minzdrav of Russia (Sechenov University); Research Institute for Uronephrology and Human Reproductive Health

Email: rektorat@mma.ru
Academician of the RAS, Dr.Med.Sci., Prof., Rector; Director

Yu. G Alyaev

I.M. Sechenov First MSMU of Minzdrav of Russia (Sechenov University); Research Institute for Uronephrology and Human Reproductive Health

Email: ugalyaev@mail.ru
Corr.-Member of the RAS, Dr.Med.Sci., Prof., Head of Department of Urology; Director of the Urology Clinic

A. V Amosov

I.M. Sechenov First MSMU of Minzdrav of Russia (Sechenov University)

Email: amosov-av@yandex.ru
Dr.Med.Sci., Prof. at the Department of Urology

G. E Krupinov

I.M. Sechenov First MSMU of Minzdrav of Russia (Sechenov University)

Email: gekrupinov@mail.ru
Dr.Med.Sci., Prof. at the Department of Urology

References

  1. Чиссов В.И., Алексеев Б.Я., Русаков И.Г. Онкоурология. Национальное руководство. М.: ГЭОТАР-Медиа. 2012; 688.
  2. Chang S.S., Gaudin P.B., Reuter V.E., Heston W.D.W. Prostate-specific membrane antigen: Present and future applications. Urology. 2000; 55(5):622-629.
  3. Boyle P., Ferlay J. Cancer incidence and mortality in Europe 2004. Ann Oncol. 2005; 16(3):481-488.
  4. Каприн А.Д., Старинский В.В., Петрова Г.В. Состояние онкологической помощи населению России в 2013 году. М.: 2014; 250
  5. Велиев Е.И., Соколов Е.А., Лоран О.Б. Улучшение рецидивной выживаемости после радикальной простатэктомии при местнораспространенном раке предстательной железы в зависимости от срока оперативного вмешательства. Онкоурология. 2016;1(12): 69-73
  6. Пушкарь Д.Ю. Радикальная простатэктомия. М.: МЕДпресс-информ. 2002; 168
  7. Abdollah F. et al. Survival benefit of radical prostatectomy in patients with localized prostate cancer: estimations of the number needed to treat according to tumor and patient characteristics. J. Urol. 2012;188:73-83.
  8. Augustin H., Hammerer P., Graefen M. Intraoperative and perioperative morbidity of contemporary radical retropubic prostatectomy in a consecutive series of 1243 patients: results of a single center between 1999 and 2002. Eur. Urol. 2003;43 (2):113-118.
  9. Петров С.Б., Велиев Е.И. Хирургическое лечение локализованных форм рака предстательной железы. Практ. онкология. 2001;2(6):50-52
  10. Isbarn H., Wanner M., Salomon G., Steuber T., Schlomm T., Köllermann J., Sauter G., Haese A., Heinzer H., Huland H., Graefen M. Long-term data on the survival of patients with prostate cancer treated with radical prostatectomy in the prostate-specific antigen era. BJU Int. 2010; 106(1):37-43.
  11. Porter C.R., Kodama K., Gibbons R.P., Correa R.Jr., Chun F.K-H., Perrotte P., Karakiewicz P.I. 25-year prostate cancer control and survival outcomes: a 40-year radical prostatectomy single institution series. Urol. 2006; 176(2):569-574.
  12. Peeters S.T.H., Heemsbergen W.D., Koper P.C.M., van Putten W.L.J., Slot A., Dielwart M.F.H., Bonfrer J.M.G., Incrocci L., Lebesque J.V. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J. Clin Oncol. 2006; 24(13):1990-1996.
  13. Warde P. et al. Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial. Lancet. 2011;378:2104-2111.
  14. Wilt T.J. et al. Radical prostatectomy versus observation for localized prostate cancer. N. Engl. J. Med. 2012; 367:203-213.
  15. Переверзев A.C., Коган М.И. Рак простаты. Харьков: Факт. 2004; 231
  16. Соловов В.А., Орлов А.Е., Воздвиженский М.О. и др. Высокоинтенсивная фокусированная ультразвуковая аблация (HIFU) рака предстательной железы у 976 пациентов: 7-летние результаты. Известия Самарского научного центра Российской академии наук. 2015;2(3):682-685
  17. Nguyen D.P., Giannarini G., Seiler R. et al. Local recurrence after retropubic radical prostatectomy for prostate cancer does not exclusively occur at the anastomotic site. bJu Int. 2013;112(4):E243-249.
  18. Черняев В.А., Матвеев В.Б., Волкова М.И., Никифорова З.Н., Шевченко В.Е. Факторы прогноза биохимического рецидива локализованного и местно-распространенного рака простаты после радикальной простатэктомии. Онкоурология. 2012;4:58-64
  19. Babaian R.J., Troncoso P., Bhadkamkar V.A., Johnston D.A. Analysis of clinicopathologic factors predicting outcome after radical prostatectomy. Cancer. 2001; 91(8):1414-1422.
  20. Асланиди И.П. и др. Диагностика рецидива рака предстательной железы по данным ПЭТ/КТ С11 C-холином у пациентов после радикальной простатэктомии. Медицинская радиология и радиационная безопасность. 2015;5(60):50-58
  21. Kataja V.V., Bergh J. ESMO minimum clinical recommendations for diagnosis, treatment and follow - up of prostate cancer. Ann Oncol. 2005;16(Suppl. 1):34-36.
  22. Mottet N., Bastian P.J., Bellmunt J., van de Burgh R.C.N., Bolla M., van Casteren N.J. et al. EAU guidelines on prostate cancer. Update April 2014. European Association of Urology. Available at: http://www.uroweb.org/ guidelines/onlineguidelines/
  23. D’Amico A.V., Moul J., Carroll P.R. et al. Prostate specific antigen doubling time as a surrogate end point for prostate cancer specific mortality following radical prostatectomy or radiation therapy. J. Urol. 2004;172(5):42-46.
  24. Stephenson A.J., Scardino P.T., Eastham J.A. et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J. Clin Oncol. 2005;23:7005-7012.
  25. Сивков А.В., Муравьев В., Кешишев Н.Г., Шадеркин И.А., Шкабко О.В. «Спасительные» методы лечения рака предстательной железы после радикальной терапии. Экспериментальная и клиническая урология. 2010;4
  26. Brockman J.A., Alanee S., Vickers A.J. et al. Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy. European Urology. 2015;67(6): 1160-1167.
  27. Uchida T., Sanghvi N.T., Gardner T.A., Koch M.O., Ishii D., Minei S. et al. Transrectal high-intensity focused ultrasound for treatment of patients with stage T1b-2n0m0 localized prostate cancer: a preliminary report. Urology. 2002;59(3):394-398; discussion 398-399.
  28. Фомкин Р.Н., Шатылко Т.В. Надир ПСА как основной предиктор рецидива локализованного рака простаты после HIFU-аблации. Новости хирургии. 2016;5(24):489- 496
  29. Рыбалов М.А., Аль-Шукри С.Х., Боровец С.Ю. Современные методы визуализации рецидивов рака предстательной железы и перспективы их развития. Урологические ведомости. 2015;1(5):7-10
  30. Aus G., Abbou C.C., Bolla M. et al. European Association of Urology. EAU guidelines on prostate cancer. Eur Urol. 2005; 48:546-551.
  31. Pucar D., Sella T., Schoder H. The role of imaging in the detection of prostate cancer local recurrence after radiation therapy and surgery. Curr Opin Urol. 2008; 18:87-97.
  32. Evangelista L., Zattoni F., Rossi E. et. al. Early detection of prostate cancer relapse by biochemistry and diagnostic imaging. Q. J. Nucl Med Mol Imaging. 2015;59(4):359-373.
  33. Ахвердиева Г.И. и др. Мультипараметрическая магнитно-резонансная томография в диагностике локального рецидива рака предстательной железы после радикальной простатэктомии. Онкоурология. 2015;4(11):72- 80
  34. Gastaldi E., Gallo F., Chiono L., Giberti C. Salvage low-dose-rate brachytherapy for prostate cancer local recurrence after radical prostatectomy: our first three patients. Urologia. 2014;81(1):46-50.
  35. Muller B.G., Kaushal A., Sankineni S. et al. Multiparametric magnetic resonance imaging-transrectal ultrasound fusion-assisted biopsy for the diagnosis oflocal recurrence after radical prostatectomy. Urol Oncol. 2015;33(10):425.
  36. Лишманова Ю.Б., Чернова В.И. Радионуклеидная диагностика для практических врачей. Томск. 2004; 394
  37. Heidenreich А., Bolla M., Joniau S. Рекомендации по лечению рака предстательной железы. European Association of Urology. 2012;164.
  38. Beresford M.J., Gillatt D., Benson R.J. et al. A systematic review of the role of imaging before salvage radiotherapy for post-prostatectomy biochemical recurrence. Clin Oncol (R Coll Radiol). 2010; 22:46-55.
  39. Fuchsjager M., Akin O., Shukla-Dave A. et al. The role of MRI and MRSI in diagnosis, treatment selection, and post-treatment follow-up for prostate cancer. Clin Adv Hematol Oncol. 2009; 7(3):193-202.
  40. Rouviere O., Vitry T., Lyonnet D. Imaging of prostate cancer local recurrences: why and how? Eur Radiol. 2010; 20:1254-1266.
  41. Casciani E., Polettini E., Carmenini E., et al. Endorectal and dynamic contrast-enhanced MRI for detection of local recurrence after radical prostatectomy. AJR. 2008;190:1187-1192.
  42. Cirillo S., Petracchini M., Scotti L. et al. Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging. Eur Radiol. 2009;19:761-769.
  43. Sciarra A., Panebianco V., Salciccia S. et al. Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. Eur Urol. 2008;54:589-600.
  44. Wassberg С., Akin O., Alberto Vargas H. et al. The Incremental Value of Contrast-Enhanced MRI in the Detection of Biopsy-Proven Local Recurrence of Prostate Cancer After Radical Prostatectomy: Effect of Reader Experience. AJR Am J. Roentgenol. 2012;199(2):360-366.
  45. Глыбочко П.В., Аляев Ю.Г., Амосов А.В. и др. Локальный рецидив рака предстательной железы у пациентов после радикальной простатэктомии. Современные методы диагностики и лечения (эндоректальная магнитно-резонансная томография с контрастным усилением, гистосканирование, ВИФУ). Урология. 2014;5:72-76
  46. Linder B.J., Kawashima A., Woodrum D.A. Early localization of recurrent prostate cancer after prostatectomy by endorectal coil magnetic resonance imaging. Can J. Urol. 2014;21(3):7283-7289.
  47. Wahart A., Guy J.B., Vallard A. et al. Intensity-modulated salvage radiotherapy with simultaneous integrated boost for local recurrence of prostatecarcinoma: a pilot study on the place of PET-choline for guiding target volume delineation. Br J Radiol. 2016;89:1058.
  48. Picchio M., Briganti A., Fanti S. et al. The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer. Eur. Urol. 2011; 59(1):51-60.
  49. Leventis A.K., Shariat S.F., Slawin K.M. Local recurrence after radical prostatectomy: correlation of US features with prostatic fossa biopsy findings. Radiology. 2001;219:432-439.
  50. Koppie T.M., Grossfeld G.D., Nudell D.M. et al. Is anastomotic biopsy necessary before radiotherapy after radical prostatectomy? J. Urol. 2001;166:111-115.
  51. Roach I.M., Hanks G., Thames Jr. H., Schelhammer P., Shipley W.U., Sokol G.E., Sandler H. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix consensus conference. Int J. Radiat Oncol Biol Phys. 2006;65(4):965-974.
  52. MacDonald О.К., Schild S.E., Vora S., Andrews P.E., Ferrigni R.G., Novicki V., Swanson S.K., Wong W.W. Salvage radiotherapy for men with isolated rising PSA or local palpable recurrence after radical prostatectomy: do outcomes differ? Urology. 2004;64(4):760-764.
  53. Stephenson A.J., Scardino P.T., Kattan M.W., Pisansky T.M., Slawin K.M., Klein E.A., Anscher M.S., Michalski J.M., Sandler H.M., Lin D.W., Forman J.D., Zelefsky M.J., Kestin L.L., Roehrborn C.G., Catton C.N., DeWeese T.L., Liauw S.L., Valicenti R.K., Kuban D.A., Pollack A. Predicting outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J. Clin Oncol. 2007;25(15):2035-2041.
  54. Swanson G.P., Hussey M.A., Tangen C.M., Chin J., Messing E., Canby-Hagino E., Forman J.D., Thompson I.M., Crawford E.D. Predominant treatrment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794. J. Clin Oncol. 2007;25(6):222-229.
  55. Egewa S., Matsumoto K., Suyama K., Soh S., Kuwao S., Iwamura M. Limited suppression of prostate specific antigen after salvage radiotherapy for its isolated elevation after radical prostatectomy. Urology. 1999;53(1):148-155.
  56. Сивков А.В., Рощин Д.А., Кешишев Н.Г., Шадеркин И.А., Цой А.А. Высокоинтенсивная фокусированная ультразвуковая терапия и другие методы лечения местного рецидива рака предстательной железы. Экспериментальная и клиническая урология. 2013;3:40-47
  57. Tasso M., Varvello F., Ferrando U. Prostate cancer: transrectal high-intensity focused ultrasound for the treatment of local recurrence after radical prostatectomy or radiotherapy. Urologia. 2009; 76(2):73-76.
  58. Asimakopoulos A.D., Miano R., Virgili G., Vespasiani G., Finazzi Agro E. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study. Urol Oncol. 2012. Vol. 30(5):577-583.
  59. Hayashi M., Shinmei S., Asano K. Transrectal high-intensity focused ultrasound for treatment for patients with biochemical failure after radical prostatectomy. Int J. Urol. 2007; 14(11):1048-1050.
  60. Murota-Kawano A., Nakano M., Hongo S., Shoji S., Nagata Y., Uchida T. Salvage high-intensity focused ultrasound for biopsy-confirmed local recurrence of prostate cancer after radical prostatectomy. BJU Int. 2010;105(12):1642-1645.
  61. Атдуев В.А., Любарская Ю.О., Ледяев Д.С. и др. Цистэктомия при местном рецидиве рака предстательной железы после радикальной простатэктомии. Медицинский альманах. 2015;2(37):64-67
  62. Pfister D., Porres D., Epplen R. et al. Palliative radical (cysto)prostatectomy in locally advanced castration-resistant prostate cancer. Urologe A. 2011;50(9):1101-1105.
  63. Kaffenberger S.D., Keegan K.A., Bansal N.K., Morgan T.M., Tang D.H., Barocas D.A., Penson D.F., Davis R., Clark P.E., Chang S.S., Cookson M.S., Herrell S.D., Smith J.A. Salvage robotic assisted laparoscopic radical prostatectomy: a single institution, 5-year experience. J. Urol. 2013;189(2):507-513.
  64. Spiess P.E., Given R.W., Jones J.S. Achieving the «bifecta» using salvage cryotherapy for locally recurrent prostate cancer: analysis of the Cryo On-Line Data (COLD) registry data. BJU Int. 2012;110(2):217-220.
  65. Langenhuijsen J.F., Broers E.M., Vergunst H. Cryosurgery for Prostate Cancer: an Update on Clinical Results of Modern Cryotechnology. Eur Urol. 2009;55(1):52-55.
  66. Strom T.J., Wilder R.B., Fernandez D.C. et al. High-dose-rate brachytherapy with or without intensity modulated radiation therapy as salvage treatment for an isolated, gross local recurrence of prostate cancer post-prostatectomy. Brachytherapy. 2014;13(2):123-127.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies